Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7th 2010"

被引：6

作者：

Ascierto, Paolo A. ^{[1
]}

De Maio, Eleonora ^{[1
]}

Bertuzzi, Stefano ^{[2
]}

Palmieri, Giuseppe ^{[3
]}

Halaban, Ruth ^{[4
]}

Hendrix, Mary ^{[5
]}

Kashani-Sabet, Mohamed ^{[6
]}

Ferrone, Soldano ^{[7
]}

Wang, Ena ^{[8
,9
]}

Cochran, Alistair ^{[10
]}

Rivoltini, Licia ^{[11
]}

Lee, Peter P. ^{[12
]}

Fox, Bernard A. ^{[13
,14
]}

Kirkwood, John M. ^{[15
,16
]}

Ullmann, Claudio Dansky ^{[17
]}

Lehmann, Frederic F. ^{[18
]}

Sznol, Mario ^{[19
]}

Schwartzentruber, Douglas J. ^{[20
]}

Maio, Michele ^{[21
]}

Flaherty, Keith ^{[22
]}

Galon, Jerome ^{[23
]}

Ribas, Antoni ^{[24
]}

Yang, James ^{[25
]}

Stroncek, David F. ^{[8
,9
]}

Mozzillo, Nicola ^{[1
]}

Marincola, Franco M. ^{[8
,9
]}

机构：

[1] Fdn Pascale, Ist Nazl Tumori, Dept Melanoma Sarcoma & Head & Neck Dis, Naples, Italy

[2] NIH, Off Director, Off Sci Policy Anal, Off Sci Policy, Bethesda, MD 20892 USA

[3] CNR, Inst Biomol Chem, Unit Canc Genet, Sassari, Italy

[4] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA

[5] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA

[6] Calif Pacific Med Ctr, Res Inst, Ctr Melanoma Res & Treatment, San Francisco, CA USA

[7] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

[8] NIH, IDIS, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA

[9] NIH, Ctr Human Immunol, Bethesda, MD 20892 USA

[10] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[11] IRCCS Fdn, Ist Nazl Tumori, Unit Immunotherapy Human Tumors, Milan, Italy

[12] Stanford Univ, Dept Med, Stanford, CA 94305 USA

[13] Providence Portland Med Ctr, Lab Mol & Tumor Immunol, Robert W Franz Canc Res Ctr, Earle A Chiles Res Inst, Portland, OR USA

[14] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA

[15] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Inst Canc, Pittsburgh, PA USA

[16] Pittsburgh Canc Inst, Melanoma Program, Pittsburgh, PA 15213 USA

[17] NCI, Clin Invest Branch, Canc Therapy Evaluat Program DCTD, Bethesda, MD 20892 USA

[18] GlaxoSmithKline Biol, Canc Immunotherapeut Business Unit, Rixensart, Belgium

[19] Yale Canc Ctr, New Haven, CT USA

[20] Indiana Univ, Hlth Goshen Ctr Canc Care, Goshen, IN USA

[21] Univ Siena, Hosp Siena, Ist Toscano Tumori, I-53100 Siena, Italy

[22] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

[23] INSERM, U872, Cordeliers Res Ctr, Inserm Grp Leader,Team 15, Paris, France

[24] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Med, Los Angeles, CA 90024 USA

[25] NIH, Bethesda, MA USA

来源：

JOURNAL OF TRANSLATIONAL MEDICINE | 2011年 / 9卷

关键词：

PRIMARY CUTANEOUS MELANOMA; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; CELLS; PROTEIN; TUMORS;

D O I：

10.1186/1479-5876-9-32

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

100103 [病原生物学]; 100218 [急诊医学];

摘要：

Progress in understanding the molecular basis of melanoma has made possible the identification of molecular targets with important implications in clinical practice. In fact, new therapeutic approaches are emerging from basic science and it will be important to implement their rapid translation into clinical practice by active clinical investigation. The first meeting of Melanoma Research: a bridge Naples-USA, organized by Paolo A. Ascierto (INT, Naples, Italy) and Francesco Marincola (NIH, Bethesda, USA) took place in Naples, on 6-7 December 2010. This international congress gathered more than 30 international and Italian faculty members and was focused on recent advances in melanoma molecular biology, immunology and therapy, and created an interactive discussion across Institutions belonging to Government, Academy and Pharmaceutical Industry, in order to stimulate new approaches in basic, translational and clinical research. Four topics of discussion were identified: New pathways in Melanoma, Biomarkers, Clinical Trials and New Molecules and Strategies.

引用

页数：12

共 29 条

[1]

Melanoma: A model for testing new agents in combination therapies [J].

Ascierto, Paolo A. ;

Streicher, Howard Z. ;

Sznol, Mario .

JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8

[2]

Natural immunity to cancer in humans [J].

Bindea, Gabriela ;

Mlecnik, Bernhard ;

Fridman, Wolf-Herman ;

Pages, Franck ;

Galon, Jerome .

CURRENT OPINION IN IMMUNOLOGY, 2010, 22 (02) :215-222

[3]

Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO

[4]

2-5

[5]

Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma [J].

Critchley-Thorne, Rebecca J. ;

Yan, Ning ;

Nacu, Serban ;

Weber, Jeffrey ;

Holmes, Susan P. ;

Lee, Peter P. .

PLOS MEDICINE, 2007, 4 (05) :897-911

[6]

Impaired interferon signaling is a common immune defect in human cancer [J].

Critchley-Thorne, Rebecca J. ;

Simons, Diana L. ;

Yan, Ning ;

Miyahira, Andrea K. ;

Dirbas, Frederick M. ;

Johnson, Denise L. ;

Swetter, Susan M. ;

Carlson, Robert W. ;

Fisher, George A. ;

Koong, Albert ;

Holmes, Susan ;

Lee, Peter P. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (22) :9010-9015

[7]

Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine [J].

Filipazzi, Paola ;

Valenti, Roberta ;

Huber, Veronica ;

Pilla, Lorenzo ;

Canese, Paola ;

Iero, Manuela ;

Castelli, Chiara ;

Mariani, Luigi ;

Parmiani, Giorgio ;

Rivoltini, Licia .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) :2546-2553

[8]

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma [J].

Flaherty, Keith T. ;

Puzanov, Igor ;

Kim, Kevin B. ;

Ribas, Antoni ;

McArthur, Grant A. ;

Sosman, Jeffrey A. ;

O'Dwyer, Peter J. ;

Lee, Richard J. ;

Grippo, Joseph F. ;

Nolop, Keith ;

Chapman, Paul B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (09) :809-819

[9]

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome [J].

Galon, Jerom ;

Costes, Anne ;

Sanchez-Cabo, Fatima ;

Kirilovsky, Amos ;

Mlecnik, Bernhard ;

Lagorce-Pages, Christine ;

Tosolini, Marie ;

Camus, Matthieu ;

Berger, Anne ;

Wind, Philippe ;

Zinzindohoue, Franck ;

Bruneval, Patrick ;

Cugnenc, Paul-Henri ;

Trajanoski, Zlatko ;

Fridman, Wolf-Herman ;

Pages, Franck .

SCIENCE, 2006, 313 (5795) :1960-1964

[10]

The adaptive immunologic microenvironment in colorectal cancer:: A novel perspective [J].

Galon, Jerome ;

Fridman, Wolf-Herman ;

Pages, Franck .

CANCER RESEARCH, 2007, 67 (05) :1883-1886

← 1 2 3 →